NUS Financial Facts
Selling expenses: 241.88MDiluted (in shares): 60.57M
See Full Income Statement
Other liabilities: 92.94M
Accrued expenses: 250.58M
See Full Balance Sheet
Earnings History for Nu Skin Enterprises Inc. (NUS)
|
Expand Research on NUS
| Next EPS Date | 7/25/13 *Est. | EPS Growth Rate | +21.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +10.5% | Revenue Growth Rate | +19.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | +7.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/13  |
 |
Q113 | $0.90 | $0.80 | +$0.10 | $550.1M | $506.52M | N/A / N/A |  |
+19.3% | Details |
| 2/6/13 |
|
Q412 | $0.97 | $0.94 | +$0.03 | $588.2M | $579.5M | N/A / N/A | |
+43.6% | Details |
| 10/31/12 |
|
Q312 | $0.87 | $0.77 | +$0.10 | $526.2M | $480.72M | $0.80 / $488.59M | = | +47.2% | Details |
| 7/26/12 |
|
Q212 | $0.94 | $0.83 | +$0.11 | $593.2M | $511.2M | $0.83 / $516.83M | |
+40.3% | Details |
| 4/26/12 |
Q112 | $0.74 | $0.70 | +$0.04 | $462M | $446.99M | $0.73 / $451.48M | |
+3.1% | Details | |
| 2/2/12 | Q411 | $0.76 | $0.72 | +$0.04 | $495.3M | $480.78M | $0.70 / $479M | |
0% | Details | |
| 10/25/11 |
|
Q311 | $0.72 | $0.61 | +$0.11 | $428M | $415.57M | N/A / N/A | |
+34.2% | Details |
| 8/2/11 |
|
Q211 | $0.65 | $0.59 | +$0.06 | $424.4M | $406.51M | N/A / N/A | |
+65.3% | Details |
